AVTX: Avalo Therapeutics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | Fell below 5% | Nantahala Capital Management, LLC | 3.54% | SEC | |
| 2026-08-14 | 13G amendment | Caligan Partners LP | 5.90% | SEC | |
| 2026-08-14 | 13G amendment | RA Capital Management, L.P. | 6.30% | SEC | |
| 2026-08-14 | 13G amendment | BIOTECHNOLOGY VALUE FUND L P | 5.30% | SEC | |
| 2026-08-14 | Fell below 5% | T. Rowe Price Investment Management, Inc. | 0.00% | SEC | |
| 2026-08-14 | Fell below 5% | Avoro Capital Advisors LLC | 4.44% | SEC | |
| 2026-08-14 | 13G amendment | Deep Track Capital, LP | 6.87% | SEC | |
| 2026-08-13 | 13G amendment | Affinity Asset Advisors, LLC | 5.50% | SEC | |
| 2026-08-07 | 13G stake raised | FMR LLC | 10.80% | +1.10 pts | SEC |
| 2026-08-07 | New 13G stake | STATE STREET CORPORATION | 5.50% | SEC | |
| 2026-08-06 | 13G amendment | FMR LLC | 9.70% | SEC | |
| 2026-07-27 | New 13G stake | BlackRock, Inc. | 6.50% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.